SmiLe Incubator

Yazen is a digital healthcare platform specializing in personalized weight loss programs. It connects users with medical professionals, including doctors, dietitians, and personal trainers, to create tailored weight management plans combining lifestyle coaching and medical treatments.

Call Knut is a company that develops communication software aimed at monitoring elderly individuals, particularly those with chronic diseases. The company's innovative platform leverages artificial intelligence to facilitate phone calls and initiate automated conversations with seniors. This technology allows caregivers and family members to assess the well-being of elderly users by analyzing their voice during calls, which helps in detecting potential health issues. By focusing on effective and unobtrusive monitoring, Call Knut aims to enhance the quality of remote care for the elderly population.

Producer of edible, bio-based, and food-safe packaging intended to reduce food loss and waste along the supply chain through sustainable alternatives. The company's platform technology is fully scalable and is the only available edible alternative that complies with EU regulations for fruits and vegetables with edible peels, enabling clients to ensure more food reaches consumers around the world.

Manje Health is a search and discovery platform for chronic disease treatment.

Xaga Surgical innovates safer medical needles to minimize infection risks. Its proprietary needle design reduces bacterial transfer upon insertion, enhancing patient safety during procedures like prostate cancer diagnosis.

TIGERQ specializes in gene editing solutions, combining proprietary sequencing algorithms with efficient sample processing services. The company focuses on commercializing services related to CRISPR-Cas9 technology for accurate analysis of complex genetic changes, aiming to accelerate drug research and development.

Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.

In2cure is a biotechnology company focused on developing innovative peptide-based drugs aimed at preventing and treating inflammatory diseases and infections. The company harnesses new scientific discoveries related to natural host defenses to create therapies that feature anti-endotoxic properties. In2cure's drugs are designed using sequences that mimic protein fragments naturally found in the human body, which allows for the production of anti-inflammatory medications that are less toxic and more soluble. This approach not only enhances the efficacy of the treatments but also promotes the generation of healing peptides during instances of wounding and inflammation.

Thyrolytics is a company focused on developing an innovative diagnostic device that measures serum levels of free T4 and T3, key thyroid hormones. Utilizing advanced nanotechnology and protein engineering, Thyrolytics offers a platform that provides direct measurements of thyroid hormone levels, enhancing the accuracy and reliability of the results. This approach results in a cost-effective point-of-care diagnostic method, enabling individuals to effectively monitor their thyroid health. By addressing the need for precise and accessible thyroid diagnostics, Thyrolytics aims to improve health outcomes for those managing thyroid conditions.

ReceptorPharma is a drug discovery company focused on developing innovative treatments for Alzheimer's disease through a novel mechanism of action. The company aims to address the needs of patients with early Alzheimer's who retain their cognitive abilities, potentially reversing the disease's effects. In addition to Alzheimer's, ReceptorPharma is also engaged in researching and developing therapies for various other debilitating conditions, including specific types of cancer, by utilizing G-protein-coupled receptors as drug targets. Through its unique approach, ReceptorPharma seeks to advance therapeutic options for patients facing challenging health issues.

Bionamic specializes in streamlining life science data analysis by automating manual steps between raw data and results. Its platform serves as a centralized hub for antibody-related discovery and development data, empowering researchers to navigate and interpret their data effectively.

SAGA Diagnostics AB is a Swedish company specializing in personalized cancer diagnostics and disease monitoring through molecular genetic analyses, focusing on circulating tumor DNA (ctDNA). Founded in 2016 as a spin-out from a research group at Lund University, SAGA aims to enhance precision cancer medicine and improve patient survival rates with its minimally-invasive liquid biopsy testing services. The company provides a range of services, including gene mutation analysis and treatment monitoring, utilizing advanced technologies such as massively parallel sequencing. SAGA's proprietary tests enable oncologists and biopharmaceutical companies to detect actionable mutations, stratify patient groups, and monitor treatment responses with high sensitivity, thereby contributing significantly to advancements in cancer research and clinical diagnostics.

Medow designs and develops innovative healthcare products aimed at enhancing efficiency, patient comfort, and joy. Their flagship product is a reusable slap-on bracelet designed to securely hold intravenous tubes in place during treatments, reducing the need for frequent adjustments by nurses.

Medotemic develops healthcare mobile systems for objective gait deviation analysis, typically resulting from injury or pain. The platform collects sensor data via smartphones during walking and running and analyzes it with proprietary algorithms to generate movement parameters. It provides training tools to measure progress, raise awareness, and motivate adherence to a training plan, and enables remote monitoring by delivering immediate, objective feedback to patients and professionals to support treatment and recovery.

POOW Applications has developed The Food Hero app that helps children with different types of eating disorders.

Gedea Biotech develops an antibiotic-free treatment for vaginal fungal infections using its substance GA101. This natural substance lowers pH, provides physical barrier protection, and inhibits biofilm formation. The company's first product is a topical treatment for vaginal fungal infections.

Truly Labs specializes in preclinical research services for drug discovery and development. They offer expertise in cell-based assays, biomarker analysis, animal models, imaging technologies, and inhalation studies to help pharmaceutical and biotechnology clients accelerate therapeutic development.

Founded in 2014, Cellevate specializes in developing advanced 3D cell culture systems using nanofiber technology. Its patented platform enables the creation of consistent and porous networks of nanofibers, serving as realistic in-vitro models for scientific research and development across various industries.

MedVasc specializes in developing innovative medical devices. Its flagship product is a patented device designed to minimize pain during varicose vein treatments by facilitating pain-free local anesthesia from within the vein.

Speximo AB is a research-based company located in Lund, Sweden, specializing in sustainable emulsion stabilization technology. Founded in 2012, the company develops a patented emulsifier derived from quinoa starch, which enables the creation of surfactant-free Pickering-type emulsions. These emulsions are applicable in the cosmetics, pharmaceutical, and food industries, allowing for the formulation of environmentally friendly products such as creams and ointments. Speximo's technology not only stabilizes emulsions but also facilitates the encapsulation of high-value ingredients, enhancing the texture and efficacy of end products. The company collaborates closely with researchers from Lund University and Malmö University to explore the fundamental properties and applications of its technology, contributing to the advancement of sustainable practices in product development.

SARomics Biostructures AB is a Swedish company specializing in structural biology and structure-based drug discovery services for biotech and pharmaceutical companies, as well as non-profit institutions globally. Founded in 2006 and located in Lund, the company provides a comprehensive suite of services that includes crystallography, NMR spectroscopy, and gene-to-structure solutions, which encompass protein cloning, expression, purification, and structure determination. Additionally, SARomics offers kinase structures and related programs, hit identification, optimization services, and computational chemistry. Their work aids clients in understanding the interactions between drug substances and target molecules, facilitating the efficient development of new drugs. The company’s expertise in protein characterization and structure-activity relationship optimization further enhances its capability to support drug discovery projects from initial concept through to lead generation.